Understanding how mutations in cardiac myosin affect heart disease and drug response
Modeling Hidden Myosin Structural States to Predict Drug Specificity and Disease Phenotypes
This study is looking at how changes in a heart protein called β-cardiac myosin can lead to heart problems, and it aims to find better ways to use existing medications to help treat these conditions, which could lead to new options for patients with heart disease.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-11008911 on NIH RePORTER |
What this research studies
This research investigates the role of mutations in β-cardiac myosin, which are linked to serious heart conditions known as cardiomyopathies. By modeling the structural states of myosin, the research aims to uncover how these mutations influence disease phenotypes and how existing drugs can be made more effective. The approach involves analyzing the binding dynamics of myosin inhibitors to improve drug specificity, which is crucial for developing targeted therapies. Patients may benefit from insights that could lead to new treatment options for heart disease.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with cardiomyopathies, particularly those with mutations in β-cardiac myosin.
Not a fit: Patients without cardiomyopathies or those whose conditions are unrelated to β-cardiac myosin mutations may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of targeted therapies that significantly improve treatment outcomes for patients with cardiomyopathies.
How similar studies have performed: Previous research has shown promise in understanding myosin dynamics and drug specificity, suggesting that this approach could yield valuable insights.
Where this research is happening
Saint Louis, United States
- Washington University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Meller, Artur — Washington University
- Study coordinator: Meller, Artur
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.